News

The Nicorette product is being manufactured and packaged by Cambrex Zenara in its Hyderabad, India facility. Cambrex president and CEO Steven Klosk said that Nicotine Replacement Therapeutics represent

According to the agreement, Seattle Genetics is expected to receive an upfront of $8m from Pfizer. Under the agreement, Pfizer has the responsibility for manufacturing, research and commercialization

As per the agreement, Lupin is expected to supply the tuberculosis drug to Farmanguinhos for next 5 years and will support the company in establishing a local manufacturing

Sumavel DosePro offers fast-acting, easy-to-use, needle-free subcutaneous administration of sumatriptan as a potential treatment alternative to oral and nasal triptans, and simple, convenient administration when compared to traditional,

AdeTherapeutics is a specialty pharma company based in Saskatoon, Saskatchewan, focused on providing quality therapeutic options in inflammation and acute care medicine. AdeTherapeutics president and CEO Sanj Singh

AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for the healthcare companies. AMRI president and CEO Thomas D’Ambra said

The clinical trial was designed to compare a new solid oral dose formulation of LX4211 to the liquid dose formulation. The study results showed that 300mg solid oral

Under the agreement, Ziopharm will use Intrexon’s UltraVector Technology to develop and commercialize DNA-based therapeutics. Ziopharm will utilize Intrexon’s advanced transgene engineering platform to facilitate the controlled and

As per the terms of the agreement, Amgen has the option for the exclusive worldwide license of XmAb 5871 following the completion of a pre-defined Phase 2 study.